Yuncheng Bei

637 total citations
14 papers, 474 citations indexed

About

Yuncheng Bei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yuncheng Bei has authored 14 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Yuncheng Bei's work include Immune cells in cancer (4 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Yuncheng Bei is often cited by papers focused on Immune cells in cancer (4 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Yuncheng Bei collaborates with scholars based in China, Ireland and United States. Yuncheng Bei's co-authors include Pingping Shen, Weijie Zhang, Wenlong Zhang, Qin Liu, Huifang Su, Yan Lü, Jie Shen, Ling Liu, Wei Zheng and Hanren Dai and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Yuncheng Bei

14 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuncheng Bei China	9	276	253	150	59	46	14	474
Sara Caratelli Italy	11	281 1.0×	215 0.8×	154 1.0×	76 1.3×	41 0.9×	15	495
Maria Liousia United States	11	236 0.9×	119 0.5×	122 0.8×	81 1.4×	65 1.4×	16	412
Alison Jaccard Switzerland	3	237 0.9×	298 1.2×	162 1.1×	40 0.7×	85 1.8×	4	485
Natalie Woodman United Kingdom	7	223 0.8×	125 0.5×	137 0.9×	78 1.3×	20 0.4×	12	362
Marissa Cunetta United States	6	357 1.3×	230 0.9×	78 0.5×	102 1.7×	23 0.5×	6	467
Pavlina Chuntova United States	10	187 0.7×	128 0.5×	177 1.2×	63 1.1×	83 1.8×	15	415
Raziye Piranlioglu United States	9	251 0.9×	276 1.1×	199 1.3×	57 1.0×	92 2.0×	13	517
Kyle B. Lupo United States	9	380 1.4×	448 1.8×	99 0.7×	26 0.4×	52 1.1×	12	584
Xuewen Tan China	8	148 0.5×	162 0.6×	177 1.2×	33 0.6×	66 1.4×	9	399
Conall Hayes Ireland	8	247 0.9×	179 0.7×	139 0.9×	63 1.1×	95 2.1×	16	447

Countries citing papers authored by Yuncheng Bei

Since Specialization

Citations

This map shows the geographic impact of Yuncheng Bei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuncheng Bei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuncheng Bei more than expected).

Fields of papers citing papers by Yuncheng Bei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuncheng Bei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuncheng Bei. The network helps show where Yuncheng Bei may publish in the future.

Co-authorship network of co-authors of Yuncheng Bei

This figure shows the co-authorship network connecting the top 25 collaborators of Yuncheng Bei. A scholar is included among the top collaborators of Yuncheng Bei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuncheng Bei. Yuncheng Bei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bei, Yuncheng, et al.. (2025). A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors. EMBO Molecular Medicine. 17(2). 365–383. 2 indexed citations

Bei, Yuncheng, Sijie Wang, Rui Wang, et al.. (2024). CDK5-triggered G6PD phosphorylation at threonine 91 facilitating redox homeostasis reveals a vulnerability in breast cancer. Acta Pharmaceutica Sinica B. 15(3). 1608–1625. 2 indexed citations

Yang, Nanfei, et al.. (2024). An electrochemical immunosensor for sensitive and rapid detection of cystatin C based on Fe3O4/AuNPs-MWCNTs@PDA nanocomposite. Analytical Biochemistry. 696. 115677–115677. 5 indexed citations

Bei, Yuncheng, Jian He, Sijie Wang, et al.. (2023). Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma. Cancer Research. 83(14). 2405–2420. 10 indexed citations

Yang, Nanfei, Bing Chen, Yuncheng Bei, et al.. (2023). A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharmaceutica Sinica B. 13(7). 3027–3042. 12 indexed citations

Bei, Yuncheng, Yanhong Chu, Zhichen Sun, et al.. (2023). Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressing universal T cell receptor‐engineered T (HAUL TCR‐T) cell therapy in solid tumor. Bioengineering & Translational Medicine. 8(6). e10585–e10585. 6 indexed citations

Wu, Xiang, Jia Wei, Zhonglei He, et al.. (2023). Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer. British Journal of Cancer. 129(3). 551–562. 42 indexed citations

Yang, Nanfei, Qiang Tian, Qiuping Wang, et al.. (2022). Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions. Cell Death and Differentiation. 30(3). 766–778. 12 indexed citations

Wang, Sijie, Yuncheng Bei, Qiang Tian, et al.. (2022). PFKFB4 facilitates palbociclib resistance in oestrogen receptor‐positive breast cancer by enhancing stemness. Cell Proliferation. 56(1). e13337–e13337. 11 indexed citations

10.

Bei, Yuncheng, Nan Cheng, Ting Chen, et al.. (2020). CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy. Advanced Science. 7(22). 2001417–2001417. 38 indexed citations

11.

Cheng, Nan, Yuncheng Bei, Yue Song, et al.. (2020). B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy. Biochemical Pharmacology. 183. 114298–114298. 54 indexed citations

12.

Zhang, Wenlong, Ling Liu, Huifang Su, et al.. (2019). Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix. British Journal of Cancer. 121(10). 837–845. 223 indexed citations

13.

Bei, Yuncheng, Jiajia Chen, Feifei Zhou, et al.. (2016). BZ-26, a novel GW9662 derivate, attenuated inflammation by inhibiting the differentiation and activation of inflammatory macrophages. Biomedicine & Pharmacotherapy. 84. 730–739. 6 indexed citations

14.

Feng, Xiujing, Tingzhe Sun, Yuncheng Bei, et al.. (2013). S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis. Scientific Reports. 3(1). 1814–1814. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact